封面
市场调查报告书
商品编码
1699463

伴同性动物关节炎市场(依动物类型、适应症、治疗方法、通路和地区划分)

Companion Animal Arthritis Market, By Animal Type, By Indication, By Treatment, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球伴同性动物关节炎市场规模估计为 46.7 亿美元,预计到 2032 年将达到 78 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 7.6%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 46.7亿美元
效能资料 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 7.60% 2032年价值预测 78亿美元
数字。伴同性动物关节炎市场占有率(%),按地区划分(2025 年)
伴侣动物关节炎市场-IMG1

骨关节炎(OA)是一种影响狗和猫的常见疾病。其特征是低度发炎进行性退化性关节疾病。骨关节炎是由关节软骨的退化和异常修復引起的,与软骨下骨骼代谢的改变、骨赘和滑膜发炎有关。在伴同性动物中,OA 最常见的原因是关节鬆弛、骨软骨症或创伤等潜在异常。这是一个涉及骨膜纤维化和骨膜反应的病理过程,导致步态和运动范围的改变。这会导致肌肉骨骼系统和次级关节稳定装置的劣化,并由于异常负荷和磨损导致关节软骨进一步劣化。

市场动态:

全球伴同性动物关节炎市场主要受到新型治疗药物不断增加的市场投放的推动。例如,加拿大卫生研究院(CIHR)资助了一项价值 60 万美元的电脑辅助设计(CAD)计划,该项目于 2021 年启动,重点评估间质干细胞治疗犬骨关节炎的有效性。该研究将对患有肘部或距骨骨关节炎的顾客所拥有的狗进行一项随机、双盲、安慰剂对照的临床试验(来源:CIHR计划资金)。这些研究的结果可能为新再生医学的潜力提供有价值的见解。此外,先进治疗方案的出现可能会鼓励更多的饲主主人在兽医的帮助下主动管理宠物的关节炎。预计这将在可预见的未来推动伴同性动物关节炎市场的持续扩张。

本研究的主要特点

  • 本报告对全球伴同性动物关节炎市场进行了详细分析,并提供了预测期(2025-2032)的市场规模和年复合成长率(CAGR%),假设 2024 年为基准年。
  • 它还揭示了不同领域的潜在商机,并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 该报告根据公司亮点、产品系列、关键亮点、财务表现和策略等参数,概述了全球伴同性动物关节炎市场的主要企业。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球伴同性动物关节炎市场报告针对该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员将透过全球伴同性动物关节炎市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管情景
  • 服务产品组合
  • PEST分析
  • 波特分析
  • 併购场景
  • 管道分析

4. 全球伴同性动物关节炎市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年全球伴同性动物关节炎市场(依动物类型)

  • 其他的

6. 2020 年至 2032 年全球伴同性动物关节炎市场(依适应症划分)

  • 骨关节炎
  • 其他关节炎

7. 2020 年至 2032 年全球伴同性动物关节炎市场(依治疗方法)

  • 药物
  • NSAIDs
  • 单株抗体
  • 其他药物
  • 补充
  • 其他治疗方法

8. 2020 年至 2032 年全球伴同性动物关节炎市场(依通路划分)

  • 兽医诊所
  • 零售药局
  • 网路商店
  • 其他的

9. 2020 年至 2032 年全球伴同性动物关节炎市场(按地区)

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第十章 竞争格局

  • Vetoquinol
  • NexGen Pharmaceuticals
  • Norbrook
  • Eltech K-Laser srl
  • Zoetis
  • Virbac
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Dechra Pharmaceuticals PLC
  • Others Prominent Players

第 11 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6525

Global Companion Animal Arthritis Market is estimated to be valued at USD 4.67 Bn in 2025 and is expected to reach USD 7.8 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.67 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.60% 2032 Value Projection: USD 7.8 Bn
Figure. Companion Animal Arthritis Market Share (%), By Region 2025
Companion Animal Arthritis Market - IMG1

Osteoarthritis (OA) is a common condition that affects dogs and cats. It is characterized as a low-grade inflammatory, progressive degenerative joint disease. OA results from degeneration and aberrant repair of articular cartilage in association with alterations in subchondral bone metabolism, osteophytosis, and synovial inflammation. In companion animals, OA is almost always secondary to an underlying abnormality, such as joint laxity, osteochondrosis, trauma, etc. It is a pathological process that includes joint capsule fibrosis and periosteal reactions, leading to an altered gait and range of motion. In turn, there is a deterioration of the musculoskeletal system and secondary joint stabilizers, resulting in further deterioration of articular cartilage due to abnormal loading and wear.

Market Dynamics:

The global companion animal arthritis market is mainly driven by the increasing development of novel therapeutics. For instance, the Canadian Institutes of Health Research (CIHR) funded a US$600,000 Computer-aided design (CAD) project launched in 2021 focused on evaluating the efficacy of mesenchymal stem cells for the treatment of osteoarthritis in dogs. The study involves a randomized, double-blinded, placebo-controlled clinical trial involving client-owned dogs with elbow or stifle osteoarthritis (source: CIHR project funding). Findings from these studies will provide valuable insights into the potential of new regenerative medicine options. Furthermore, the greater availability of advanced treatment choices will encourage more pet owners to actively manage their pet's arthritis with the help of veterinarians. This, in turn, will fuel ongoing expansion in the companion animal arthritis market beyond the foreseeable future.

Key features of the study:

  • This report provides in-depth analysis of the global companion animal arthritis market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global companion animal arthritis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Vetoquinol, NexGen Pharmaceuticals, Norbrook, Eltech K-Laser s.r.l, Zoetis, Virbac, Elanco, Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC .
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global companion animal arthritis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global companion animal arthritis market

Global Companion animal arthritis Market Detailed Segmentation:

  • By Animal Type
    • Dogs
    • Cats
    • Others
  • By Indication
    • Osteoarthritis
    • Other Arthritis
  • By Treatment
    • Medication
    • NSAIDs
    • Monoclonal Antibodies
    • Others Medications
    • Supplements
    • Other Treatment
  • By Distribution Channel
    • Veterinary Hospitals & Clinics
    • Retail Pharmacies
    • Online Stores
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Vetoquinol
    • NexGen Pharmaceuticals
    • Norbrook
    • Eltech K-Laser s.r.l
    • Zoetis
    • Virbac
    • Elanco
    • Boehringer Ingelheim International GmbH
    • Ceva
    • Dechra Pharmaceuticals PLC
    • Others Prominent Players .

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Companion Animal Arthritis Market, By Animal Type
    • Global Companion Animal Arthritis Market, By Treatment
    • Global Companion Animal Arthritis Market, By Indication
    • Global Companion Animal Arthritis Market, By Distribution Channel
    • Global Companion Animal Arthritis Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising Concerns About Self-Image and Confidence
    • Side effects of treatment options
    • Untapped emerging markets
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Service offering Portfolio
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Pipeline Analysis

4. Global Companion Animal Arthritis Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Companion Animal Arthritis Market, By Animal Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Dogs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Cats
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Companion Animal Arthritis Market, By Indication, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Osteoarthritis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Other Arthritis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Companion Animal Arthritis Market, By Treatment, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Medication
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • NSAIDs
  • Monoclonal Antibodies
  • Others Medications
  • Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Other Treatments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Companion Animal Arthritis Market, By Distribution Channel, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Veterinary Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Online Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Companion Animal Arthritis Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Vetoquinol
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • NexGen Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Norbrook
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Eltech K-Laser s.r.l
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Zoetis
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Virbac
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Elanco
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ceva
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Dechra Pharmaceuticals PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others Prominent Players
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us